FilingSEC EDGAR6-K
Clearmind Medicine Presents Clinical Insights at FDA Psychedelic Hearing
· SEC accepted
StageClinical
Filing content
Clearmind Medicine testified at an FDA hearing on the potential therapeutic use of psychedelic drugs, sharing insights from its clinical trials.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…